Organigram Holdings Inc. Investing cash flow

Investing cash flow of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Investing cash flow growth rates and interactive chart.


Highlights and Quick Summary

  • Investing cash flow for the quarter ending May 31, 2022 was $40.3 Million (a -324.36% decrease compared to previous quarter)
  • Year-over-year quarterly Investing cash flow increased by 1077.05%
  • Annual Investing cash flow for 2021 was $-92 Million (a -13.06% decrease from previous year)
  • Annual Investing cash flow for 2020 was $-106 Million (a 188.37% increase from previous year)
  • Annual Investing cash flow for 2019 was $-36.7 Million (a -52.04% decrease from previous year)
  • Twelve month Investing cash flow ending May 31, 2022 was $67.7 Million (a -167.71% decrease compared to previous quarter)
  • Twelve month trailing Investing cash flow decreased by -169.71% year-over-year
Trailing Investing cash flow for the last four month:
31 May '22 28 Feb '22 30 Nov '21 31 Aug '21
$67.7 Million $-100 Million $-67.2 Million $-97.1 Million
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Investing cash flow of Organigram Holdings Inc.

Most recent Investing cash flowof OGI including historical data for past 10 years.

Interactive Chart of Investing cash flow of Organigram Holdings Inc.

Organigram Holdings Inc. Investing cash flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $40.31 $-17.97
2021 $41.93 $3.42 $-127.36 $14.81 $-91.98
2020 $12.01 $-30.72 $-20.43 $-25.98 $-105.79
2019 $-25.68 $5.22 $-12.64 $-9.51 $-36.69
2018 $-18.36 $-76.74 $-76.5
2017 $-31.49
2016 $-20.76

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic